Among cancer patients with stage III and IV ovarian and basal-like breast cancer, PRF1 expression levels correlate with the infiltration of CD8+ T cells, dendritic cells, and neutrophils [34,35,36]. This evidence concerns the gene PRF1 and breast carcinoma.